Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn's disease.
Amino acid metabolism
Inflammation
Inflammatory bowel disease
Microbiology
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
23 05 2022
23 05 2022
Historique:
received:
29
11
2021
accepted:
07
04
2022
pubmed:
13
4
2022
medline:
25
5
2022
entrez:
12
4
2022
Statut:
epublish
Résumé
Elucidating how resident enteric bacteria interact with their hosts to promote health or inflammation is of central importance to diarrheal and inflammatory bowel diseases across species. Here, we integrated the microbial and chemical microenvironment of a patient's ileal mucosa with their clinical phenotype and genotype to identify factors favoring the growth and virulence of adherent and invasive E. coli (AIEC) linked to Crohn's disease. We determined that the ileal niche of AIEC was characterized by inflammation, dysbiosis, coculture of Enterococcus, and oxidative stress. We discovered that mucosal metabolites supported general growth of ileal E. coli, with a selective effect of ethanolamine on AIEC that was augmented by cometabolism of ileitis-associated amino acids and glutathione and by symbiosis-associated fucose. This metabolic plasticity was facilitated by the eut and pdu microcompartments, amino acid metabolism, γ-glutamyl-cycle, and pleiotropic stress responses. We linked metabolism to virulence and found that ethanolamine and glutamine enhanced AIEC motility, infectivity, and proinflammatory responses in vitro. We connected use of ethanolamine to intestinal inflammation and L-fuculose phosphate aldolase (fucA) to symbiosis in AIEC monoassociated IL10-/- mice. Collectively, we established that AIEC were pathoadapted to utilize mucosal metabolites associated with health and inflammation for growth and virulence, enabling the transition from symbiont to pathogen in a susceptible host.
Identifiants
pubmed: 35413017
pii: 157013
doi: 10.1172/jci.insight.157013
pmc: PMC9220930
doi:
pii:
Substances chimiques
Ethanolamines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDDK NIH HHS
ID : P01 DK094779
Pays : United States
Organisme : NIH HHS
ID : P40 OD010995
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK114252
Pays : United States
Références
Antibiotics (Basel). 2020 Jul 30;9(8):
pubmed: 32751519
Cell Host Microbe. 2015 Oct 14;18(4):489-500
pubmed: 26468751
Physiol Rev. 2014 Apr;94(2):329-54
pubmed: 24692350
J Mol Med (Berl). 2017 Sep;95(9):905-913
pubmed: 28528514
Cell Host Microbe. 2021 Apr 14;29(4):607-619.e8
pubmed: 33539767
Cell Host Microbe. 2016 Aug 10;20(2):133-43
pubmed: 27512901
Sci Rep. 2019 Feb 18;9(1):2175
pubmed: 30778122
Nature. 2016 Jul 06;535(7610):85-93
pubmed: 27383983
Traffic. 2015 Jan;16(1):1-18
pubmed: 25243850
Cells. 2019 Nov 05;8(11):
pubmed: 31694333
Mucosal Immunol. 2017 Jan;10(1):18-26
pubmed: 27554295
Gut Microbes. 2011 Jan-Feb;2(1):58-60
pubmed: 21637020
ISME J. 2007 Sep;1(5):403-18
pubmed: 18043660
mBio. 2018 Oct 2;9(5):
pubmed: 30279284
PLoS Pathog. 2019 Jul 11;15(7):e1007815
pubmed: 31295324
J Biol Chem. 2020 Jul 24;295(30):10493-10505
pubmed: 32503843
PLoS One. 2012;7(7):e41594
pubmed: 22848538
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
Sci Rep. 2020 Jul 29;10(1):12686
pubmed: 32728059
J Immunol. 2015 Jun 15;194(12):5588-93
pubmed: 26048966
J Gastroenterol. 1999 Feb;34(1):46-53
pubmed: 10204610
J Bacteriol. 2015 Jul;197(14):2412-21
pubmed: 25962913
Semin Immunol. 2013 Nov 30;25(5):334-41
pubmed: 24239045
Infect Immun. 2008 Mar;76(3):1143-52
pubmed: 18180286
Mol Microbiol. 2015 Jun;96(6):1272-82
pubmed: 25807888
mBio. 2016 Mar 01;7(2):e01748
pubmed: 26933054
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6
pubmed: 18936492
Nat Commun. 2019 Jul 26;10(1):3354
pubmed: 31350417
Nat Commun. 2015 Sep 22;6:8292
pubmed: 26392213
Inflamm Bowel Dis. 2019 Aug 20;25(9):1481-1496
pubmed: 30889246
Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19496-9
pubmed: 17159144
Pathogens. 2019 Jun 08;8(2):
pubmed: 31181736
Nat Microbiol. 2019 Feb;4(2):293-305
pubmed: 30531976
Sci Rep. 2016 Apr 25;6:24834
pubmed: 27109914
Sci Rep. 2016 Dec 13;6:38899
pubmed: 27958326
Can J Biochem. 1980 Dec;58(12):1381-6
pubmed: 7018652
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Dig Dis Sci. 1996 Oct;41(10):2078-86
pubmed: 8888724
Nature. 2020 Feb;578(7796):527-539
pubmed: 32103191
Inflamm Bowel Dis. 2009 May;15(5):653-60
pubmed: 19023901
Gastroenterology. 2019 Sep;157(3):647-659.e4
pubmed: 31014995
EBioMedicine. 2019 May;43:325-332
pubmed: 31036531
Cell Host Microbe. 2019 Feb 13;25(2):301-312.e5
pubmed: 30683582
Gastroenterology. 2017 Feb;152(2):327-339.e4
pubmed: 27769810
Metabolites. 2019 Jun 27;9(7):
pubmed: 31252628
World J Biol Chem. 2020 Apr 7;11(1):1-13
pubmed: 32405343
Gut. 2018 Mar;67(3):574-587
pubmed: 29141957
Inflamm Bowel Dis. 2014 Nov;20(11):1919-32
pubmed: 25230163
Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17480-5
pubmed: 21969563
Inflamm Bowel Dis. 2019 Apr 11;25(5):875-885
pubmed: 30576451
Gastroenterology. 2004 Aug;127(2):412-21
pubmed: 15300573
Sci Transl Med. 2017 Feb 8;9(376):
pubmed: 28179509
Environ Microbiol. 2021 May;23(5):2564-2577
pubmed: 33754467
Infect Immun. 1992 Sep;60(9):3943-6
pubmed: 1500206
Genome Biol. 2012 Apr 16;13(9):R79
pubmed: 23013615
Curr Opin Microbiol. 2021 Oct;63:19-28
pubmed: 34107380
Cancers (Basel). 2021 May 13;13(10):
pubmed: 34068419
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19820-5
pubmed: 24248342
J Bacteriol. 1995 Oct;177(19):5434-9
pubmed: 7559326
Cell Mol Gastroenterol Hepatol. 2021;11(2):525-550
pubmed: 32961355
J Infect Dis. 2010 Jul 1;202(1):52-64
pubmed: 20497056
Cell Host Microbe. 2014 Mar 12;15(3):382-392
pubmed: 24629344
Gut Microbes. 2011 Nov-Dec;2(6):335-46
pubmed: 22157238
Infect Immun. 2006 Aug;74(8):4778-92
pubmed: 16861666
Nat Microbiol. 2020 Jan;5(1):116-125
pubmed: 31686025
Environ Microbiol. 2011 Feb;13(2):365-77
pubmed: 20849446